WST•benzinga•
West Pharmaceutical Stock Sinks On Weaker Than Expected 2025 Guidance
Summary
West Pharmaceutical reported Q4 earnings and revenue above expectations but issued a weak 2025 forecast. William Blair reiterated its Outperform rating.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on February 13, 2025 by benzinga